Does the equipment comply with international standards?

The hardware follows ASME BPE, software complies with GAMP5, and complete IQ/OQ/PQ verification files are provided to meet FDA/EMA requirements.

Does it support multi-country voltage?

Standard wide voltage input (100-380V, 50/60Hz), customizable for specific country voltages such as 230V in Europe and 120V in the United States.

How to obtain technical support overseas?

We provide remote diagnostic services (with customer authorization) and respond within 48 hours.

How long is the spare parts supply cycle?

Standard spare parts are urgently shipped within 72 hours worldwide, while customized components need to be pre-ordered 4 weeks in advance.

Do you provide process training?

Optional online training or on-site guidance including Chinese/English manuals, covering equipment operation, maintenance, and troubleshooting.

Automatic Controlled Liquid Preparation System for Inhalant Drug Mixing

Name: Automatic Controlled Liquid Preparation System for Inhalant Drug Mixing
Brand: Nanjing BioWill Biological Engineering Co., Ltd.
SKU: 2224544035

Jiangsu, ChinaNanjing BioWill Biological Engineering Co., Ltd.

US$5,000.00-1,000,000.00

1 Set

Product profile

Customization

Available

Application

Chemical Industry, Food Industry, Pharmaceutical Industry, Culture Medium/Buffer Preparation and Distribution

Certification

GMP

Model NO.

BWM-S

Control System

PLC and HMI;Fully Automatic

Customized

Material

Stainless Steel, 316L

Delivery Time

2-3 Months

Volume

5-5000L Customizable

Height to Diameter Ratio

1-3 Customizable

Design Pressure

-1~4 Bar

Mixing Drive

Single End Mechanical Seal, Double End Mechanical

Mixing Forms

Paddle Type, Propulsion Type, Anchor Type

Temperature Control Methods

Various Forms Such as Electric Heating,

Discharge Methods

Gas Pressure Discharge, Centrifugal Pump Discharge

Level Measurement

Load Cell or Liquid Level Gauge

CIP/SIP

Support, One Click Operation

Verification Documents

Dq/Iq/Oq/Pq/Fs/Hds/SDS, etc. Comply with EU and Fd

Transport Package

Export Standard Package

Specification

5-5000L

Trademark

Biowill

Origin

China

HS Code

8479820090

Production Capacity

1000sets/Year

Key features

Full Process Automation: Closed-loop control from weighing to filling reduces human intervention risk.

GMP Compliant Design: Meets GMP A-level cleanliness with integrated SIP/CIP for sterile assurance.

High Precision Mixing: Dynamic hybrid technology ensures CV value less than 5% for consistency.

Complete Validation Docs: Provides DQ/IQ/OQ/PQ files to meet FDA and EMA audit requirements.

Customizable Volume: Flexible volume range from 5 to 5000 liters to suit various production needs.

Modular Architecture: ISA-88 BATCH standard supports rapid switching for multi-product co-production.

Aseptic Transfer Interface: Prevents cross-contamination during drug transfer and processing.

One Click CIP/SIP: Supports one-click operation for cleaning and sterilization processes.

Company profile

Importers and ExportersHigh Repeat Buyers ChoiceMulti-language PioneerSelf-branded

Nanjing BioWill Biological Engineering Co., Ltd.

Jiangsu, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc.Average Response Time: ≤2.87h CertifiedTerms of Payment: LC, T/T, D/P, etc. CertifiedInternational Commercial Terms(Incoterms): FOB, CIF, CFR, EXW

AI-Powered supplier vetting

SummaryThe supplier presents evidence of professional technical and R&D capabilities, including 3D software design, SDK availability, recent new-product development, ODM services, and OEM services for well-known brands. It reports broad customization capability and maintains multiple welding, drilling, cutting, and sawing facilities. Its business scope covers pharmaceutical special equipment, industrial automation, intelligent instruments, experimental analysis instruments, and related technical services. Service-related corrective action and customer complaint procedures are documented and followed, although the assessment procedure for effective service capability lacks written procedures or records. Financial records are indicated for 2022–2024, but no financial strength conclusion can be made from the provided dates alone. The supplier reports regular fire drills but lacks a factory environmental impact assessment report. No certification holdings or specific customer cases are provided.

Supplier typeThe supplier is identified as a professional technical supplier and a combined company. Its stated scope includes manufacturing and sales of pharmaceutical special equipment, industrial automation devices, intelligent instruments, experimental analysis instruments, and related technical development and engineering services.

After-Sales capabilityThe supplier has clear procedures and followed records for corrective and preventive actions and for handling customer complaints. However, its assessment procedure for effective supplier service capability is reported as having no written procedures or followed records, indicating a documented weakness in service-capability assessment.

R&D capabilityThe supplier reports professional R&D capability, available SDKs, 3D software design services, at least one new product in the past year, ODM services, and technical development activities within its business scope. These are explicit indicators of innovation and product-development capability.

Production capacityProduction resources include automatic welding, drilling, laser welding, pipe cutting, sawing, and welding facilities. The supplier also states that it manufactures pharmaceutical special equipment, industrial automation devices, experimental analysis instruments, and intelligent instruments, supporting a positive assessment of manufacturing breadth.

Customization capabilityThe supplier explicitly offers customization from samples, customization from designs, full customization, minor customization, and flexible customization. This consistent evidence across its R&D and facility-related profiles supports broad customization capability.